Document And Entity Information
Document And Entity Information | Mar. 22, 2022 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Mar. 22, 2022 |
Entity Registrant Name | CinCor Pharma, Inc. |
Entity Central Index Key | 0001868734 |
Entity Emerging Growth Company | true |
Entity File Number | 001-41201 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 36-4931245 |
Entity Address, Address Line One | 200 Clarendon Street |
Entity Address, Address Line Two | 6th Floor |
Entity Address, City or Town | Boston |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02116 |
City Area Code | 844 |
Local Phone Number | 531-1834 |
Entity Information, Former Legal or Registered Name | Not Applicable |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Ex Transition Period | true |
Title of 12(b) Security | Common Stock, $0.00001 par value per share |
Trading Symbol | CINC |
Security Exchange Name | NASDAQ |